Literature DB >> 27484894

Cerebral circulation in aging.

Ken Nagata1, Takashi Yamazaki2, Daiki Takano2, Tetsuya Maeda3, Yumi Fujimaki4, Taizen Nakase4, Yuichi Sato5.   

Abstract

Cerebral circulation is known to be protected by the regulatory function against the hypoperfusion that will affect the cognitive function as a result of brain ischemia and energy failure. The regulatory function includes cerebrovascular autoregulation, chemical control, metabolic control, and neurogenic control, and those compensatory mechanisms can be influenced by hypertension, atherosclerosis, cardiac diseases, cerebrovascular diseases and aging. On the other hand, large and/or small infarction, intracranial hemorrhage, subarachnoid hemorrhage, atherosclerosis, amylod angiopathy are also more directly associated with cognitive decline not only in those with vascular cognitive impairment or vascular dementia but also those with Alzheimer's disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27484894     DOI: 10.1016/j.arr.2016.06.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  24 in total

1.  Aerobic exercise prevents rarefaction of pial collaterals and increased stroke severity that occur with aging.

Authors:  Wojciech Rzechorzek; Hua Zhang; Brian K Buckley; Kunjie Hua; Daniel Pomp; James E Faber
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-07       Impact factor: 6.200

Review 2.  Relationship between cognitive function and regulation of cerebral blood flow.

Authors:  Shigehiko Ogoh
Journal:  J Physiol Sci       Date:  2017-02-03       Impact factor: 2.781

Review 3.  Optical imaging and modulation of neurovascular responses.

Authors:  Kazuto Masamoto; Alberto Vazquez
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-18       Impact factor: 6.200

Review 4.  Review: Relationship of type 2 diabetes to human brain pathology.

Authors:  J J Pruzin; P T Nelson; E L Abner; Z Arvanitakis
Journal:  Neuropathol Appl Neurobiol       Date:  2018-03-04       Impact factor: 8.090

Review 5.  The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment.

Authors:  Osigbemhe Iyalomhe; Sabina Swierczek; Ngozi Enwerem; Yuanxiu Chen; Monica O Adedeji; Joanne Allard; Oyonumo Ntekim; Sheree Johnson; Kakra Hughes; Philip Kurian; Thomas O Obisesan
Journal:  Cell Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.046

6.  The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.

Authors:  Andrew L Callen; Sara M Dupont; Jeffrey Pyne; Jason Talbott; Phyllis Tien; Evan Calabrese; David Saloner; Felicia C Chow; Jared Narvid
Journal:  J Neurovirol       Date:  2020-06-04       Impact factor: 2.643

7.  Imaging transcranial Doppler ultrasound to measure middle cerebral artery blood flow: the importance of measuring vessel diameter.

Authors:  Catherine L Jarrett; Katherine L Shields; Ryan M Broxterman; Jay R Hydren; Soung Hun Park; Jayson R Gifford; Russell S Richardson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-13       Impact factor: 3.619

Review 8.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases.

Authors:  Meher R Juttukonda; Manus J Donahue
Journal:  Neuroimage       Date:  2017-10-12       Impact factor: 6.556

9.  Changes in Cerebral Arteries and Parenchymal Arterioles With Aging: Role of Rho Kinase 2 and Impact of Genetic Background.

Authors:  T Michael De Silva; Mary L Modrick; Fabrice Dabertrand; Frank M Faraci
Journal:  Hypertension       Date:  2018-03-12       Impact factor: 10.190

10.  Evaluation of cerebral autoregulation performance in patients with arterial hypertension on drug treatment.

Authors:  Michel Ferreira Machado; Henrique Cotchi Simbo Muela; Valeria Aparecida Costa-Hong; Monica Sanches Yassuda; Natalia Cristina Moraes; Claudia Maia Memória; Edson Bor-Seng-Shu; Ayrton Roberto Massaro; Ricardo Nitrini; Luiz Aparecido Bortolotto; Ricardo de Carvalho Nogueira
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.